Corrigendum: Next-Generation Sequencing Approaches for the Identification of Pathognomonic Fusion Transcripts in Sarcomas: The Experience of the Italian ACC Sarcoma Working Group.

NGS anchored multiplex PCR fusion transcripts hybrid capture-based panel molecular diagnosis sarcoma

Journal

Frontiers in oncology
ISSN: 2234-943X
Titre abrégé: Front Oncol
Pays: Switzerland
ID NLM: 101568867

Informations de publication

Date de publication:
2020
Historique:
received: 11 05 2020
accepted: 13 05 2020
entrez: 14 7 2020
pubmed: 14 7 2020
medline: 14 7 2020
Statut: epublish

Résumé

[This corrects the article DOI: 10.3389/fonc.2020.00489.].

Identifiants

pubmed: 32656080
doi: 10.3389/fonc.2020.00944
pmc: PMC7324988
doi:

Types de publication

Published Erratum

Langues

eng

Pagination

944

Commentaires et corrections

Type : ErratumFor

Informations de copyright

Copyright © 2020 Racanelli, Brenca, Baldazzi, Goeman, Casini, De Angelis, Guercio, Milano, Tamborini, Busico, Dagrada, Garofalo, Caruso, Brunello, Pignochino, Berrino, Grignani, Scotlandi, Parra, Hattinger, Ibrahim, Mercatali, De Vita, Carriero, Pallocca, Loria, Covello, Sbaraglia, Dei Tos, Falcioni and Maestro.

Auteurs

Dominga Racanelli (D)

Unit of Oncogenetics and Functional Oncogenomics, Centro di Riferimento Oncologico di Aviano (CRO Aviano) IRCCS, National Cancer Institute, Aviano, Italy.

Monica Brenca (M)

Unit of Oncogenetics and Functional Oncogenomics, Centro di Riferimento Oncologico di Aviano (CRO Aviano) IRCCS, National Cancer Institute, Aviano, Italy.

Davide Baldazzi (D)

Unit of Oncogenetics and Functional Oncogenomics, Centro di Riferimento Oncologico di Aviano (CRO Aviano) IRCCS, National Cancer Institute, Aviano, Italy.

Frauke Goeman (F)

Department of Research, Diagnosis and Innovative Technology, IRCCS Regina Elena National Cancer Institute, Rome, Italy.

Beatrice Casini (B)

Department of Research, Diagnosis and Innovative Technology, IRCCS Regina Elena National Cancer Institute, Rome, Italy.

Biagio De Angelis (B)

Department of Onco-Haematology and Cell and Gene Therapy Unit, Bambino Gesù Children's Hospital, IRCCS, Rome, Italy.

Marika Guercio (M)

Department of Onco-Haematology and Cell and Gene Therapy Unit, Bambino Gesù Children's Hospital, IRCCS, Rome, Italy.

Giuseppe Maria Milano (GM)

Department of Onco-Haematology and Cell and Gene Therapy Unit, Bambino Gesù Children's Hospital, IRCCS, Rome, Italy.

Elena Tamborini (E)

Department of Pathology, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy.

Adele Busico (A)

Department of Pathology, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy.

Gianpaolo Dagrada (G)

Department of Pathology, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy.

Cecilia Garofalo (C)

Advanced Translational Research Laboratory, Veneto Institute of Oncology IOV - IRCCS, Padua, Italy.

Chiara Caruso (C)

Advanced Translational Research Laboratory, Veneto Institute of Oncology IOV - IRCCS, Padua, Italy.

Antonella Brunello (A)

Medical Oncology 1, Department of Oncology, Veneto Institute of Oncology IOV - IRCCS, Padua, Italy.

Ymera Pignochino (Y)

Division of Medical Oncology, Candiolo Cancer Institute, FPO-IRCCS, Candiolo, Italy.

Enrico Berrino (E)

Unit of Pathology, Candiolo Cancer Institute FPO-IRCCS, Candiolo, Italy.

Giovanni Grignani (G)

Division of Medical Oncology, Candiolo Cancer Institute, FPO-IRCCS, Candiolo, Italy.

Katia Scotlandi (K)

Laboratory of Experimental Oncology, IRCCS Istituto Ortopedico Rizzoli, Bologna, Italy.

Alessandro Parra (A)

Laboratory of Experimental Oncology, IRCCS Istituto Ortopedico Rizzoli, Bologna, Italy.

Claudia Maria Hattinger (CM)

Laboratory of Experimental Oncology, IRCCS Istituto Ortopedico Rizzoli, Bologna, Italy.

Toni Ibrahim (T)

Osteoncology and Rare Tumors Center, Istituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori (IRST) IRCCS, Meldola, Italy.

Laura Mercatali (L)

Osteoncology and Rare Tumors Center, Istituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori (IRST) IRCCS, Meldola, Italy.

Alessandro De Vita (A)

Osteoncology and Rare Tumors Center, Istituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori (IRST) IRCCS, Meldola, Italy.

Maria Vincenza Carriero (MV)

Tumor Progression Unit, Department of Experimental Oncology, Istituto Nazionale Tumori Fondazione "G. Pascale" IRCCS, Naples, Italy.

Matteo Pallocca (M)

Department of Research, Diagnosis and Innovative Technology, IRCCS Regina Elena National Cancer Institute, Rome, Italy.

Rossella Loria (R)

Department of Research, Diagnosis and Innovative Technology, IRCCS Regina Elena National Cancer Institute, Rome, Italy.

Renato Covello (R)

Department of Research, Diagnosis and Innovative Technology, IRCCS Regina Elena National Cancer Institute, Rome, Italy.

Marta Sbaraglia (M)

Department of Pathology, Azienda Ospedaliera Universitaria di Padova, Padua, Italy.

Angelo Paolo Dei Tos (AP)

Department of Pathology, Azienda Ospedaliera Universitaria di Padova, Padua, Italy.
Department of Medicine, University of Padua School of Medicine, Padua, Italy.

Rita Falcioni (R)

Department of Research, Diagnosis and Innovative Technology, IRCCS Regina Elena National Cancer Institute, Rome, Italy.

Roberta Maestro (R)

Unit of Oncogenetics and Functional Oncogenomics, Centro di Riferimento Oncologico di Aviano (CRO Aviano) IRCCS, National Cancer Institute, Aviano, Italy.

Classifications MeSH